a 11075 Search Results


90
BOC Sciences carboxypeptidase a1
Correlation analysis between changes (Δ) in proteins’ levels with NT-proBNP and Δhemodynamic parameters
Carboxypeptidase A1, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/carboxypeptidase a1/product/BOC Sciences
Average 90 stars, based on 1 article reviews
carboxypeptidase a1 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Correlation analysis between changes (Δ) in proteins’ levels with NT-proBNP and Δhemodynamic parameters

Journal: Heart and Vessels

Article Title: Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics

doi: 10.1007/s00380-020-01656-3

Figure Lengend Snippet: Correlation analysis between changes (Δ) in proteins’ levels with NT-proBNP and Δhemodynamic parameters

Article Snippet: Proteins analysed were N-terminal pro b-type natriuretic peptide (NT-proBNP), 5′-nucleotidase, protein AMBP (AMBP), aminopeptidase N (AP-N), bleomycin hydrolase (BLM-H), brother of cell adhesion molecule-related/down-regulated by oncogenes (CDO) or (BOC), carbonic anhydrase 9 (CA9), cathepsin Z, p21 or cyclin-dependent kinase inhibitor 1A (CDKN1A), carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 1 and 5, contactin-1, cornulin, carboxypeptidase A1 (CPA1), carboxypeptidase B (CPB1), carboxypeptidase E (CPE), cystatin B, endothelial cell-specific molecule 1 or endocan, epithelial cell adhesion molecule (Ep-CAM), furin, gastrotropin, glyoxalase I or lactoylglutathione lyase, kallikrein 6, 8, 11, 13 and 14, Ly6/PLAUR domain-containing protein 3 (LYPD3) or C4.4A, mesothelin, methionine aminopeptidase 2 (MetAP2), melanoma-derived growth regulatory protein or melanoma inhibitory activity (MIA), midkine, mucin-16 or CA125, podocalyxin, prostasin, PVRL4 or nectin-4, S100A11, S100A4, secretory carrier-associated membrane protein 3 (SCAMP3), secretoglobin family 3A member 2 (SCGB3A2), tyrosine-protein phosphatase non-receptor-type substrate 1 (SHPS-1), sortilin, T-cell leukemia/lymphoma protein 1A (TCL1A), trefoil factor 3 (TFF3), protein-glutamine gamma-glutamyltransferase 2 (TGM2), WAP four-disulfide core domain protein 2 (WFDC2), vimentin, V-set and immunoglobulin domain-containing protein 2 (VSIG2), and Xaa-Pro aminopeptidase 2 (XPNPEP2).

Techniques:

Tumour-related proteins’ levels in controls and patients before and 1-year after heart transplantation

Journal: Heart and Vessels

Article Title: Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics

doi: 10.1007/s00380-020-01656-3

Figure Lengend Snippet: Tumour-related proteins’ levels in controls and patients before and 1-year after heart transplantation

Article Snippet: Proteins analysed were N-terminal pro b-type natriuretic peptide (NT-proBNP), 5′-nucleotidase, protein AMBP (AMBP), aminopeptidase N (AP-N), bleomycin hydrolase (BLM-H), brother of cell adhesion molecule-related/down-regulated by oncogenes (CDO) or (BOC), carbonic anhydrase 9 (CA9), cathepsin Z, p21 or cyclin-dependent kinase inhibitor 1A (CDKN1A), carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 1 and 5, contactin-1, cornulin, carboxypeptidase A1 (CPA1), carboxypeptidase B (CPB1), carboxypeptidase E (CPE), cystatin B, endothelial cell-specific molecule 1 or endocan, epithelial cell adhesion molecule (Ep-CAM), furin, gastrotropin, glyoxalase I or lactoylglutathione lyase, kallikrein 6, 8, 11, 13 and 14, Ly6/PLAUR domain-containing protein 3 (LYPD3) or C4.4A, mesothelin, methionine aminopeptidase 2 (MetAP2), melanoma-derived growth regulatory protein or melanoma inhibitory activity (MIA), midkine, mucin-16 or CA125, podocalyxin, prostasin, PVRL4 or nectin-4, S100A11, S100A4, secretory carrier-associated membrane protein 3 (SCAMP3), secretoglobin family 3A member 2 (SCGB3A2), tyrosine-protein phosphatase non-receptor-type substrate 1 (SHPS-1), sortilin, T-cell leukemia/lymphoma protein 1A (TCL1A), trefoil factor 3 (TFF3), protein-glutamine gamma-glutamyltransferase 2 (TGM2), WAP four-disulfide core domain protein 2 (WFDC2), vimentin, V-set and immunoglobulin domain-containing protein 2 (VSIG2), and Xaa-Pro aminopeptidase 2 (XPNPEP2).

Techniques: